Menu
GWAS Study

Genome-wide association study of primary open-angle glaucoma in continental and admixed African populations.

Bonnemaijer PWM, Iglesias AI, Nadkarni GN et al.

30317457 PubMed ID
GWAS Study Type
12070 Participants
Scroll to explore
Chapter I

Publication Details

Comprehensive information about this research publication

Authors

BP
Bonnemaijer PWM
IA
Iglesias AI
NG
Nadkarni GN
SA
Sanyiwa AJ
HH
Hassan HG
CC
Cook C
SM
Simcoe M
TK
Taylor KD
SC
Schurmann C
BG
Belbin GM
KE
Kenny EE
BE
Bottinger EP
VD
van de Laar S
WS
Wiliams SEI
AS
Akafo SK
AA
Ashaye AO
ZL
Zangwill LM
GC
Girkin CA
NM
Ng MCY
RJ
Rotter JI
WR
Weinreb RN
LZ
Li Z
AR
Allingham RR
NA
Nag A
HP
Hysi PG
MM
Meester-Smoor MA
WJ
Wiggs JL
HM
Hauser MA
HC
Hammond CJ
LH
Lemij HG
LR
Loos RJF
VD
van Duijn CM
TA
Thiadens AAHJ
KC
Klaver CCW
Chapter II

Abstract

Summary of the research findings

Primary open angle glaucoma (POAG) is a complex disease with a major genetic contribution. Its prevalence varies greatly among ethnic groups, and is up to five times more frequent in black African populations compared to Europeans. So far, worldwide efforts to elucidate the genetic complexity of POAG in African populations has been limited. We conducted a genome-wide association study in 1113 POAG cases and 1826 controls from Tanzanian, South African and African American study samples. Apart from confirming evidence of association at TXNRD2 (rs16984299; OR[T] 1.20; P = 0.003), we found that a genetic risk score combining the effects of the 15 previously reported POAG loci was significantly associated with POAG in our samples (OR 1.56; 95% CI 1.26-1.93; P = 4.79 × 10-5). By genome-wide association testing we identified a novel candidate locus, rs141186647, harboring EXOC4 (OR[A] 0.48; P = 3.75 × 10-8), a gene transcribing a component of the exocyst complex involved in vesicle transport. The low frequency and high degree of genetic heterogeneity at this region hampered validation of this finding in predominantly West-African replication sets. Our results suggest that established genetic risk factors play a role in African POAG, however, they do not explain the higher disease load. The high heterogeneity within Africans remains a challenge to identify the genetic commonalities for POAG in this ethnicity, and demands studies of extremely large size.

484 Sub-Saharan African ancestry cases, 179 South African Coloured ancestry cases, 450 African American cases, 380 Sub-Saharan African ancestry controls, 96 South African Coloured ancestry controls, 1350 African American controls

Chapter III

Study Statistics

Key metrics and study information

12070
Total Participants
GWAS
Study Type
Yes
Replicated
1,993 Sub-Saharan African ancestry cases, 2,595 African American cases, 1,730 Sub-Saharan African ancestry controls, 2,813 African American controls
Replication Participants
Other admixed ancestry, Sub-Saharan African, African American or Afro-Caribbean
Ancestry
South Africa, United Republic of Tanzania, U.S., Ghana, Nigeria, U.K.
Recruitment Country
Chapter IV

Analysis

Comprehensive review of health and genetic findings

Important Disclaimer: This review has been performed semi-automatically and is provided for informational purposes only. While we strive for accuracy, this analysis may contain errors, omissions, or misinterpretations of the original research. DNA Genics disclaims all liability for any inaccuracies, errors, or consequences arising from the use of this information. Users should independently verify all information and consult original research publications before making any decisions based on this content. This analysis is not intended as a substitute for professional scientific review or medical advice.

Analysis In Progress

Our analysis of this publication is currently being prepared. Please check back soon for comprehensive insights into the health and genetic findings discussed in this research.